Vera Plunges as Otsuka Updates on Rival Therapy

Seeking AlphaFeb 14 14:33 ET

Wells Fargo Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $70

Moomoo NewsFeb 14 13:31 ET · Ratings

Vera Therapeutics Weakness on Otsuka Plans 'Makes No Sense,' Says Wells Fargo

TipRanksFeb 14 12:40 ET

Vera Therapeutics Down Over 19%, on Pace for Largest Percent Decrease Since January 2023 -- Data Talk

Dow JonesFeb 14 11:39 ET

This Expand Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

BenzingaFeb 4 09:15 ET

Vera Therapeutics Analyst Ratings

BenzingaFeb 4 08:17 ET · Ratings